One pot synthesis of UiO-66-NH2 containing curcumin and cytotoxic evaluation toward liver cancer cells

Chitosan and carboxymethyl cellulose coated on NH2-UiO-66 as green, biocompatible, nontoxic, and pH-stimuli responsive for levofloxacin delivery: A comparative study

Recently, developing an efficient and green approach to overcoming bacterial resistance in drug delivery systems has remained a significant challenge. This work is supposed to design and create two novel, green, biocompatible nanocarriers by incorporating levofloxacin-loaded NH2-UiO-66 into the chitosan and carboxymethyl cellulose biopolymers. The structural characteristics and antibacterial activity of the synthesized carriers were analyzed using FT-IR, SEM, BET, XRD, TGA-DTA, zeta potential, DLS, swelling analysis, ZOI, MIC, MBC, and MTT techniques. The in vitro release rate of the levofloxacin at acidic and neutral environments from the NH2-UiO-66/levofloxacin/carboxymethyl cellulose was 78±2.1% and 18±1.9% and from the NH2-UiO-66/levofloxacin/chitosan was 86±3.5% and 69±2.9% respectively, over 72 h. Kinetics studies showed that the Corsmeyer-Peppas and Higuchi models predicted the release mechanisms of NH2-UiO-66/levofloxacin/carboxymethyl cellulose (R2=0.97) and NH2-UiO-66/levofloxacin/chitosan nanocarriers R2=0.97, respectively. Additionally, studies of the antibacterial properties showed that two NH2-UiO-66/levofloxacin/carboxymethyl cellulose and NH2-UiO-66/levofloxacin/chitosan nanocarriers were more effective against Staphylococcus aureus bacteria than Escherichia coli bacteria. The MTT assay showed that after 48 h, the NH2-UiO-66/levofloxacin/carboxymethyl cellulose nanocarrier with a concentration of 8 mg/mL exhibited lower cell viability compared to the NH2-UiO-66/levofloxacin/chitosan nanocarrier. Overall, these developed nanocarriers hold promise as advanced drug delivery systems due to their strong antibacterial properties.

Cisplatin-loaded UiO-66-NH2 functionalized with folic acid enhances apoptotic activity and antiproliferative effects in MDA-MB-231 breast and A2780 ovarian cancer cells: An in vitro study

The multifunctional nature of UiO-66-NH₂ as a drug carrier positions it as an optimal candidate for encapsulating and delivering anticancer agents. This study developed a folic acid (FA)-functionalized metal-organic framework (MOF) based on UiO-66-NH₂ to facilitate the targeted delivery of cisplatin (CIS) to MDA-MB-231 breast cancer and A2780 ovarian cancer cells. Fourier transform infrared spectroscopy (FT-IR) confirmed the successful encapsulation of CIS within UiO-66-NH₂, while the drug release profile demonstrated a sustained, pH-responsive release of CIS, with a pronounced increase in the acidic tumor microenvironment. The MTT assay revealed excellent biocompatibility of UiO-66-NH₂-FA with HFF healthy cells, whereas UiO-66-NH₂-CIS-FA significantly enhanced anticancer activity against MDA-MB-231 and A2780 cells. Treatment with UiO-66-NH₂-CIS-FA induced substantial apoptosis in both cell lines, leading to a marked upregulation of BAX and P53 gene expression, alongside the downregulation of BCL2, CCND1, and CDK4. Furthermore, cells treated with CIS, UiO-66-NH₂-CIS, and UiO-66-NH₂-CIS-FA exhibited a significant increase in DCF fluorescence compared to the control group, indicating elevated ROS generation. UiO-66-NH₂-CIS-FA demonstrated enhanced drug-loading capacity and cytotoxic efficacy against cancer cells. Functionalization of UiO-66-NH₂-CIS with FA presents a promising strategy for targeted cancer therapy by improving drug delivery specificity and enhancing therapeutic outcomes.

Climate friendly MOFs synthesis for drug delivery systems by integrating AI, intelligent manufacturing, and quantum solutions in industry 6.0 sustainable approach

Since the Industrial Revolution, ecological damage, ecosystem disruption, and climate change acceleration have frequently resulted from human advancement at the price of the environment. Due to the rise in illnesses, Industry 6.0 calls for a renewed dedication to sustainability with latest technologies. Focused research and creative solutions are needed to achieve the UN Sustainable Development Goals (SDGs), especially 3, 9, 13, 14, 15, 17. A promising sustainable technology for enhancing healthcare while reducing environmental effect is Metal Organic Frameworks (MOFs). MOFs are perfect for drug administration because of their high surface areas, adjustable pore sizes, and remarkable drug-loading capacities. They are created by combining advanced artificial intelligence, intelligent manufacturing, and quantum computing. Researchers can create MOFs with functional groups or ligands that bind selectively to target cells or tissues, minimizing off-target effects, thanks to the distinct benefits that families like MIL, HKUST, UiO, and ZIF etc. offer for targeted drug delivery. Combining MOFs with other nanomaterials results in multipurpose systems that can handle challenging biomedical issues. Despite its promise, there are still issues with MOFs' possible toxicity and long-term stability in physiological settings. To advance their medicinal applications, these problems must be resolved. Researchers can increase the usefulness of MOFs in medicine by critically analysing these limitations and putting up creative alternatives. The creation of MOFs especially with advanced technologies (additive manufacturing etc.) for drug delivery is a prime example of how scientific advancement and environmental stewardship may coexist to provide healthcare solutions that are advantageous to both people and the environment.